Abstract:OBJECTIVETo investigate the effect of propofol on the activation of nuclear factor-kappa B (NF-kappa B) and the expression of inflammatory cytokines, such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and intercellular adhesion molecule-1 (ICAM-1) in cerebral cortex during transient focal cerebral ischemia-reperfusion, and to discuss the probable mechanism of its protective effect.METHODSNinety male Wistar rats were randomly divided into 3 equal groups: sham operation group undergoing sham operation; ischemia/reperfusion (I/R) group undergoing thread embolism of the left middle cerebral artery occlusion (MCAO) to cause focal ischemia for 2 hours and then undergoing reperfusion; and propofol group undergoing peritoneal injection of propofol 2 hours before the ischemia-reperfusion of MCAO. Then the rats in the 3 groups were re-divided into subgroups of 5 rats, totally 18 subgroups, to be decapitated 2, 3, 6, 12, 24, and 72 hours after reperfusion for the latter 2 groups, and their brains were taken out and fixed. Immunohistochemistry was used to detect the translocation of NF-kappaB in the neurons and the expression of IL-1, TNF-alpha, and ICAM-1 in the brain. Western blotting was used to detect the expression of NF-kappa B. The opposite non-ischemic cortexes were used as controls.RESULTSTwo to 24 hours after the reperfusion NF-kappaB was significantly translocated from the cytoplasm into the nucleus; however, NF-kappa B remained in the cytoplasm of bilateral cortexes in the sham operation groups, and the nonischemic cortexes in the I/R and protofol groups. The translocation of NF-kappa B from cytoplasm into nucleus was significantly inhibited in the ischemic cortex of the propofol group. The expression values of NF-kappa B in the nuclei of ischemic cortexes in the I/R group 2 to 24 hours after reperfusion were significantly higher than those in the sham operation group and the nonischemic cortexes of the I/R and propofol groups (all P < 0.01). The expression values of NF-kappa B in the ischemic cortex of the propofol group 2 to 24 hours after reperfusion was significantly lower than that of the I/R group (all P < 0.05). The expression values of IL-1, TNF-alpha, and ICAM-1 in the ischemic cortexes were significantly higher than that in the cortex of the sham operation group and those in the nonischemic cortexes of the I/R group and propofol group (P < 0.01 or P < 0.05) and the expression values of IL-1, TNF-alpha, and ICAM-1 in the propofol group were all significantly lower than those in the I/R group (all P < 0.05).CONCLUSIONPropofol inhibits the inflammatory reaction by inhibiting the NF-kappa B activation during focal ischemia-reperfusion which may be one of the mechanisms of its neuroprotective function.

Inhibition of Microglial Activation Contributes to Propofol-Induced Protection Against Post-Cardiac Arrest Brain Injury in Rats

Abstract T P84: Neuroprotective Effect of Probenecid in a Rat Model of Transient Global Cerebral Ischemia-Reperfusion

Propofol Pretreatment Attenuates Aquaporin-4 Over-Expression and Alleviates Cerebral Edema after Transient Focal Brain Ischemia Reperfusion in Rats

Propofol Inhibits Microglial Activation Via Mir-106B/pi3k/akt Axis.

Propofol Prevents Cerebral Ischemia-Triggered Autophagy Activation and Cell Death in the Rat Hippocampus Through the NF-κB/p53 Signaling Pathway

Propofol Attenuates Inflammatory Damage <i>via</i> Inhibiting NLRP1-Casp1-Casp6 Signaling in Ischemic Brain Injury

Blocking Conversion of GABAergic Inhibition As a Potential Mechanism of Propofol-Mediated Brain Protection Following Resuscitation

Propofol Attenuates Inflammatory Response in LPS-Activated Microglia by Regulating the miR-155/SOCS1 Pathway

Propofol post‑conditioning protects the blood brain barrier by decreasing matrix metalloproteinase‑9 and aquaporin‑4 expression and improves the neurobehavioral outcome in a rat model of focal cerebral ischemia‑reperfusion injury.

Propofol Reduces Microglia Activation and Neurotoxicity Through Inhibition of Extracellular Vesicle Release

Propofol Prevents Autophagic Cell Death Following Oxygen and Glucose Deprivation in Pc12 Cells and Cerebral Ischemia-Reperfusion Injury in Rats

Propofol Improves Brain Injury Induced by Chronic Cerebral Hypoperfusion in Rats

Propofol Reduces Inflammatory Brain Injury after Subarachnoid Hemorrhage: Involvement of PI3K/Akt Pathway

Propofol ameliorates ischemic brain injury by blocking TLR4 pathway in mice

Propofol maintains Th17/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR‑145‑3p/NFATc2/NF‑κB axis

[Effect of Propofol on the Activation of Nuclear Factor-Kappa B and Expression of Inflammatory Cytokines in Cerebral Cortex During Transient Focal Cerebral Ischemia-Reperfusion: Experiment with Rats].

Effect of Propofol on Brain Injury Induced by Intestinal Ischemia-Reperfusion in Rats

Propofol Ameliorates Microglia Activation by Targeting MicroRNA-221/222-IRF2 Axis

Propofol Increases Expression of Basic Fibroblast Growth Factor after Transient Cerebral Ischemia in Rats

Propofol administration improves neurological function associated with inhibition of pro-inflammatory cytokines in adult rats after traumatic brain injury

Propofol Attenuates Intermittent Hypoxia Induced Up-Regulation of Proinflammatory Cytokines in Microglia Through Inhibiting the Activation of NF-Bκ/p38 MAPK Signalling.